
Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …

Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …

The US Food and Drug Administration (FDA) have announced that it is altering the way it evaluates a drug’s ability …

The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …

Deaths linked to the powerful opioid fentanyl have increased by 30% in England and Wales. Figures from the Office for …

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …

Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to …

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …

Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …

Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …

Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …

Researchers at the Los Alamos National Laboratory have developed a computer simulation that is able to accurately predict the transmission …